BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling
Author:
Affiliation:
1. Lung Research Laboratory; Hanson Institute; Adelaide South Australia Australia
2. Thoracic Medicine; Royal Adelaide Hospital; Adelaide South Australia Australia
3. Department of Medicine; University of Adelaide; Adelaide South Australia Australia
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12712/fullpdf
Reference22 articles.
1. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry;Pietra;Circulation,1989
2. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era;Humbert;Circulation,2010
3. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33;Deng;Am. J. Respir. Crit. Care Med.,2000
4. Familial primary pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene;Deng;Am. J. Hum. Genet.,2000
5. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium;Lane;Nat. Genet.,2000
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling;Redox Biology;2022-12
2. Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy;Frontiers in Genetics;2022-11-24
3. MicroRNA153 induces apoptosis by targeting NFATc3 to improve vascular remodeling in pulmonary hypertension;Clinical and Experimental Hypertension;2022-11-14
4. Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective;Journal of Molecular Medicine;2022-05-24
5. New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis;Circulation Research;2022-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3